Patent · US Active

Alpha-hemolysin variants and uses thereof

US12358956B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 25, 2020
Grant dateJul 15, 2025
Priority date
Expiry dateDec 11, 2043

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/48721
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Described herein are variants of alpha-hemolysin having at least one mutation, such as a mutation to a positive charge. In certain examples, the mutation is selected from 0K, A1K, A1R, D2N, S3K, D4K, D4N, K8R, N47K, E70K, S106K, E111N, 127-131G, D128K, K147N, V149K, E287R, M298A, or combinations thereof in the mature, wild-type alpha-hemolysin amino acid sequence. Also provided are compositions including the variants of alpha-hemolysin, nanopore assemblies including the alpha-hemolysin variants, and methods of sequencing nucleic acids incorporating the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.